Peter Andreas Kopp Appointed Incoming Editor-in-Chief of Thyroid Journal

July 30, 2012 - PRLog -- New Rochelle, NY—We are pleased to announce that Peter Andreas Kopp, MD has been appointed the fourth Editor-in-Chief of Thyroid (http://www.liebertpub.com/thy), the Official Journal of the American Thyroid Association (ATA) (http://www.thyroid.org), published by Mary Ann Liebert, Inc., publishers (http://www.liebertpub.com). Dr. Kopp succeeds Charles H. Emerson, MD, who has provided strong leadership for the journal over the last five years. The latest Journal Impact Factor is 4.792.  

Dr. Peter Kopp is Associate Professor in the Division of Endocrinology, Metabolism and Molecular Medicine, and serves as Director ad interim of the Center for Genetic Medicine at the Feinberg School of Medicine of Northwestern University in Chicago. Dr. Kopp received his MD degree from the University of Berne, Switzerland in 1985. He completed his training in Internal Medicine and Endocrinology at the same institution. In 1993, he joined the Division of Endocrinology at Northwestern University. His clinical activities focus on patients with thyroid dysfunction and thyroid cancer, and he is a member of the Thyroid Panel of the National Comprehensive Cancer Network. Dr. Kopp’s research interests focus primarily on the molecular basis of congenital thyroid disorders and thyroid hormone synthesis. He is a member of the Board of Directors of the American Thyroid Association (http://www.thyroid.org), the leading organization focused on thyroid biology and the prevention and treatment of thyroid disorders. Dr. Kopp has published more than 120 publications in the field of endocrinology and endocrine genetics, including book chapters in major text books.

Dr. Kopp will assume his duties in August 2012, with a full transition to Editor-in-Chief in January 2013.

“The ATA is delighted that Dr. Peter Kopp will be the next Editor-in-Chief of Thyroid. He will succeed Charles Emerson, who deserves much credit and our gratitude for steering the journal to its present prominence,” says American Thyroid Association President James A. Fagin, MD, Memorial Sloan-Kettering Cancer Center, New York. “We are fortunate to have identified such a well-rounded scholar as the next Editor-in-Chief, and have no doubt he will have a successful tenure and take the Journal to even greater heights.”

"We are very pleased to welcome Peter Kopp as the fourth editor of Thyroid, and look forward to working with him,” says Mary Ann Liebert, President of the company that bears her name.

About the Journal
Thyroid (http://www.liebertpub.com.thy), the Official Journal of the American Thyroid Association is an authoritative peer-reviewed journal published monthly in print and online. The Journal publishes original articles and timely reviews that reflect the rapidly advancing changes in our understanding of thyroid physiology and pathology, from the molecular biology of the cell to clinical management of thyroid disorders. Complete tables of content and a sample issue may be viewed online at the Thyroid (http://www.liebertpub.com/thy) website.

About the Society
The American Thyroid Association (ATA) (http://www.thyroid.org) is the leading worldwide organization dedicated to the advancement, understanding, prevention, diagnosis, and treatment of thyroid disorders and thyroid cancer. ATA is an international membership medical society with over 1,400 members from 43 countries around the world. The ATA has extensive online information at www.thyroid.org on thyroid disease for patients in both English and Spanish and serves as the clinical resource for patients and the public who look for reliable information on the Internet.

About the Publisher
Mary Ann Liebert, Inc., publishers (http://www.liebertpub.com) is a privately held, fully integrated media company known for establishing authoritative medical and biomedical peer-reviewed journals, including Journal of Women’s Health, Diabetes Technology & Therapeutics, and Metabolic Syndrome and Related Disorders. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry’s most widely read publication worldwide. A complete list of the firm’s 70 journals, newsmagazines, and books is available at the Mary Ann Liebert, Inc., publishers (http://www.liebertpub.com) website.